Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Ensure a sterile environment, use an insulin syringe to gently add water to the vial
Highest quality peptides Our products are scientifically-formulated and produced in cGMP facilities
Summary: Retatrutide FDA Status Retatrutide is not FDA-approved and won't be for at least another year It's in Phase 3 trials (TRIUMPH program) with results expected in late 2026 FDA approval is projected for 20272028 Phase 2 data showed 24.2% weight loss , better than any approved GLP-1 medication Current access: clinical trials (free), compounded retatrutide ($200$500/mo), or research peptides ($150$500/mo) When approved, retatrutide will be the first triple-agonist obesity medication on the market References Jastreboff AM, Aronne LJ, Ahmad NN, et al
10.1152/jappl.1987.63.1.152 J Appl Physiol
US$ 28.76
US$ 27.61
US$ 20.49
US$ 28.10
US$ 24.30
